Editorial
doi: 10.1111/apt.14859.
Editorial: aminosalicylates in Crohn's disease-prevalence, risks, costs and time to re-assess?
Affiliations
- PMID: 30588694
- DOI: 10.1111/apt.14859
Item in Clipboard
Editorial
Editorial: aminosalicylates in Crohn's disease-prevalence, risks, costs and time to re-assess?
Aliment Pharmacol Ther.
2018 Aug.
No abstract available
Comment in
-
Editorial: aminosalicylates in Crohn's disease-prevalence, risks, costs and time to reassess? Authors' reply.Aliment Pharmacol Ther. 2018 Aug;48(4):489. doi: 10.1111/apt.14908. Aliment Pharmacol Ther. 2018. PMID: 30284736 No abstract available.
Comment on
-
Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease.Aliment Pharmacol Ther. 2018 Jul;48(2):114-126. doi: 10.1111/apt.14821. Epub 2018 May 30. Aliment Pharmacol Ther. 2018. PMID: 29851091
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical